Related references
Note: Only part of the references are listed.Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing
Kuang-Yu Chou et al.
ONCOLOGY REPORTS (2021)
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
Antonio Lopez-Beltran et al.
CANCERS (2021)
Attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer through targeting matrix metalloproteinase 2 expression
Kuang-Yu Chou et al.
ENVIRONMENTAL TOXICOLOGY (2021)
The global burden of urinary bladder cancer: an update
Anke Richters et al.
WORLD JOURNAL OF UROLOGY (2020)
Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells
Haifang Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
Huili Li et al.
SCIENTIFIC REPORTS (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Jinfeng Wang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
Wendan Yu et al.
CELL DEATH & DISEASE (2020)
PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer
Xiao-Li Wei et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
The Role of Autophagy in Tumor Immunology-Complex Mechanisms That May Be Explored Therapeutically
Alana Serrano Campelo de Souza et al.
FRONTIERS IN ONCOLOGY (2020)
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Francesca Nazio et al.
CELL DEATH AND DIFFERENTIATION (2019)
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Xiaojuan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
Te-Fu Tsai et al.
BIOSCIENCE REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression
Hsiao-Chi Tsai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin alpha 4 beta 1 system
An-Chen Chang et al.
CANCER LETTERS (2018)
The Roles of Autophagy in Cancer
Chul Won Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis
Feng Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease
James L. Chen et al.
MOLECULAR CANCER RESEARCH (2017)
Autophagy in cancer metastasis
E. E. Mowers et al.
ONCOGENE (2017)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis
Yi-Chia Lin et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2017)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
Cisplatin induces protective autophagy through activation of BECNI in human bladder cancer cells
Ji-Fan Lin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Joaquin Bellmunt et al.
CANCER TREATMENT REVIEWS (2017)
Inhibition of High Basal Level of Autophagy Induces Apoptosis in Human Bladder Cancer Cells
Yi-Chia Lin et al.
JOURNAL OF UROLOGY (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation
Shenghong Yang et al.
CANCER IMMUNOLOGY RESEARCH (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101)
Jens Mani et al.
BMC CANCER (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
Xi Wang et al.
CELLULAR SIGNALLING (2015)
PD-1/PD-L1 inhibitors
Joel Sunshine et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
Patcharee Ritprajak et al.
ORAL ONCOLOGY (2015)
Autophagy in inflammation, infection, neurodegeneration and cancer
Daniela S. Arroyo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Recurrence of high-risk bladder cancer: A population-based analysis
Karim Chamie et al.
CANCER (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
Apoptosis Signal-Regulating Kinase 1 Is Involved in WISP-1-Promoted Cell Motility in Human Oral Squamous Cell Carcinoma Cells
Jing-Yuan Chuang et al.
PLOS ONE (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Inhibition of autophagy impairs tumor cell invasion in an organotypic model
Robin L. Macintosh et al.
CELL CYCLE (2012)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer
Marije M. Vleugel et al.
HUMAN PATHOLOGY (2006)
Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor
C Dunn et al.
CELLULAR SIGNALLING (2002)
Share Paper
